Nazzareno Dimasi

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 8

Top Venues

Pharmaceutics

ChemMedChem

Leukemia

Molecular pharmaceutics

AstraZeneca

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca Feb 20 2007

United States

Associate Director R&D :: Antibody Discovery and Protein Engineering

Publications

Krista Kinneer, Philipp Wortmann, Zachary A Cooper, Niall J Dickinson, Luke A Masterson, Thais Cailleau, Ian Hutchinson, Balakumar Vijayakrishnan, Mary McFarlane, Kathryn Ball, Michael Davies, Arthur Lewis, Yue Huang, Anton I Rosenbaum, Jiaqi Yuan, Jon Chesebrough, Judith Anderton, Noel Monks, Steven J Novick, Jixin Wang, Nazzareno Dimasi, R James Christie, Darrin Sabol, Frances Anne Tosto, Yann Wallez, Elisabetta Leo, Mark R Albertella, Anna D Staniszewska, David A Tice, Philip W Howard, Nadia Luheshi, Puja Sapra
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Amit Kumar, Shenlan Mao, Nazzareno Dimasi, Changshou Gao
Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site. International journal of molecular sciences 21 (18) (2020)
James Steinhardt, Yanli Wu, Ryan Fleming, Ben T Ruddle, Pooja Patel, Herren Wu, Changshou Gao, Nazzareno Dimasi
Fab-Arm Exchange Combined with Selective Protein A Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly from Culture Media. Pharmaceutics 12 (1) (2019)
D Travis Gallagher, Chris McCullough, Robert G Brinson, Joomi Ahn, John P Marino, Nazzareno Dimasi
Structure and Dynamics of a Site-Specific Labeled Fc Fragment with Altered Effector Functions. Pharmaceutics 11 (10) (2019)
Jason B White, Ryan Fleming, Luke A Masterson, Ben T Ruddle, Haihong Zhong, Christine Fazenbaker, Patrick Strout, Kim Rosenthal, Molly Reed, Vanessa Muniz-Medina, Philip Howard, Rakesh Dixit, Herren Wu, Mary Jane Hinrichs, Changshou Gao, Nazzareno Dimasi
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer. mAbs 11 (3) (2019)
Ben T Ruddle, Ryan Fleming, Herren Wu, Changshou Gao, Nazzareno Dimasi
Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload. ChemMedChem 14 (12) (2019)
Krista Kinneer, Matt Flynn, Suneetha B Thomas, John Meekin, Reena Varkey, Xiaodong Xiao, Haihong Zhong, Shannon Breen, Paul G Hynes, Ryan Fleming, Binyam Bezabeh, Cui Tracy Chen, Leslie Wetzel, Ruoyan Chen, Nazzareno Dimasi, Yu-Tzu Tai, Kenneth C Anderson, Ronald Herbst, Philip W Howard, Elaine M Hurt, David A Tice
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells. Leukemia 33 (3) (2018)
Nazzareno Dimasi, Ryan Fleming, Haihong Zhong, Binyam Bezabeh, Krista Kinneer, Ronald J Christie, Christine Fazenbaker, Herren Wu, Changshou Gao
Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion. Molecular pharmaceutics 14 (5) (2017)

Nazzareno Dimasi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nazzareno Dimasi